Education and Training
MD - Lewis Katz School of Medicine at Temple University, Philadelphia, PA
PhD - Molecular and Cellular Physiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
Combined Internal Medicine and Pediatrics, Harvard/Brigham and Women's Hospital/Boston Children's Hospital, Boston, MA
Combined Adult and Pediatric Infectious Diseases, University of Pennsylvania Health System/Children's Hospital of Philadelphia, Philadelphia, PA
Internal Medicine – American Board of Internal MedicinePediatrics – American Board of Pediatrics
Titles and Academic Titles
Fellow, Division of Infectious Diseases
Departments and Services
Kulick-Soper CV, McKee JL, Wolf RL, Mohan S, Stein JM, Masur, JH, Lazor JW, Dunlap DG, McGinniss JE, David MZ, England RN, Rothstein A, Gelfand MA, Cucchiara BL, Davis KA. Pearls and Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19. Neurology 2020; 95(10): 454-57.
England RN, Pak J, Liu M, Rao S, Azono O, Levy O, van Haren SD. The Distinct Neonatal Immune Response to Toll-like Receptor 7/8 Activation is Controlled by Plasma Factors Through the Expression of Let-7g. In Submission
Gabunia K, Herman AB, Ray M, Kelemen SE, England RN, DeLa Cadena R, Foster WJ, Elliott KJ, Eguchi S, Autieri MV. Induction of MiR133a Expression by IL-19 Targets LDLRAP1 and Reduces oxLDL Uptake in VSMC. J Mol Cell Cardiol 2017; 105: 38-48.
Kako F, Gabunia K, Ray M, Kelemen SE, England RN, Kako B, Scalia RG, Autieri MV. Interleukin-19 Induces Angiogenesis in the Absence of Hypoxia by Direct and Indirect Immune Mechanisms. Am J Physiol Cell Physiol 2016; 310(11): C931-41. 2014
Ellison S, Gabunia K, Richards JM, Kelemen SE, England RN, Rudic D, Azuma YT, Munroy MA, Eguchi S, Autieri MV. IL-19 Reduces Ligation-Mediated Neointimal Hyperplasia by Reducing Vascular Smooth Muscle Cell Activation. Am J Pathol 2014; 184(7): 2134-43.
Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG Jr, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV. Attenuation of Experimental Atherosclerosis by Interleukin-19. Arteriorscler Thromb Vasc Biol 2013; 33(10): 2316-2324.
England RN, Preston KJ, Scalia R, Autieri MV. Interleukin-19 Decreases Leukocyte-Endothelial Cell Interactions by Reduction in Endothelial Cell Adhesion Molecule mRNA Stability. Am J Physiol Cell Physiol 2013; 305(3): C255-65.
Sommerville LJ, Kelemen SE, Ellison SP, England RN, Autieri MV. Increased atherosclero- sis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet. Atherosclerosis 2012; 220(1): 45-52. England RN, Autieri MV. Anti-in ammatory eects of interleukin-19 in vascular disease. Int J In amm 2012; 253583.
Gabunia K, Jain S, England RN, Autieri MV. Anti-in ammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am J Physiol Cell Physiol 2011; 300(4): C896-906.
Posters and Presentations
England RN, Liu M, Pak J, Levy O, van Haren SD. Dual TLR7/8 and Mincle Agonism in Human Newborn Dendritic Cells Induces Let-7g and miR-155 Expression. Pediatric Academic Societies 2019.
England RN, Liu M, Levy O, van Haren SD. Dual Activation of Human Dendritic Cells via TLR7/8 and the C-type Lectin Receptor Mincle Induces Let-7g and miR-155 Expression. International Precision Vaccines Conference 2017.
England RN, Kelemen S, Ellison S, Autieri MV. Identifying Mechanisms of Interleukin-19- Mediated HuR-Dependent Reduction in Vascular Cell mRNA Stability. FASEB J. 2013; 27: 648.5.
Ellison S, Gabunia K, Richards J, Kelemen SE, England RN, Scalia R, Orr AW, Berglund LM, Gomez MF, Autieri MV. Attenuation of Experimental Atherosclerosis by Interleukin-19. FASEB J. 2013; 27: 869.7.
England RN, Kelemen SE, Preston KJ, Ellison SP, Scalia R, Autieri MV. Interleukin-19 Reduces Leukocyte-Endothelial Cell Interactions. Abstracts: Arteriosclerosis, Thrombosis, and Vascular Biology 2012 Scientic Sessions. Arterioscler Thromb Vasc Biol 2012; 52.
England RN, Gabunia K, Cuneo A, Ellison S, Kelemen S, Autieri MV. IL-19 decreases ox-LDL induced VSMC activation by suppression of scavenger receptor expression and reduction of ox-LDL uptake. FASEB J. 2011;25: 39.12.
Gabunia K, Jain S, England RN, Autieri MV. The Anti-In ammatory Cytokine Interleukin-19 Inhibits Smooth Muscle Cell Migration and Activation of Cytoskeletal Regulators of VSMC Motility. FASEB J. 2011; 25:616.9.
Awards and Honors
2015, Angelo DiGeorge Prize for Excellence in Pediatrics
2015, Charles H. Kravitz, M.D. Award in Internal Medicine
2015, Carson Schneck, M.D., Ph.D. Scholarship
2011, Graduate Student Research in Pathology Award
2008, Evan Pugh Senior Scholar Award
2007, Undergraduate Summer Discovery Grant
2007, Evan Pugh Junior Scholar Award
2005, President's Freshman Award
2004-2008, Schreyer Honors College Academic Excellence Award
2004-2008, Dean's List - The Pennsylvania State University
Leadership and Memberships
Phi Beta Kappa Society
Alpha Omega Alpha Honor Medical Society (AOA)
American College of Physicians (ACP)
American Academy of Pediatrics (AAP)
Infectious Diseases Society of America (IDSA)
Pediatric Infectious Diseases Society (PIDS)
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.